Featured Press Releases

Latest SURPASS-3 Trial Data Reveals How Tirzepatide Treatment Affects Muscle Composition in Type 2 Diabetes

Latest SURPASS-3 Trial Data Reveals How Tirzepatide Treatment Affects Muscle Composition in Type 2 Diabetes

ImmPACT Bio announces FDA clearance of its IND application for CD19/CD20 bispecific CAR-T cell therapy in multiple sclerosis

ImmPACT Bio announces FDA clearance of its IND application for CD19/CD20 bispecific CAR-T cell therapy in multiple sclerosis

  • 21 Aug 2024

ImmPACT Bio USA Inc.a clinical-stage biopharmaceutical company developing a new generation of...

PRM Pharma Launches HemiClor® 12.5 mg, the First FDA-Approved Low-Dose Chlorthalidone Tablet for Hypertension

PRM Pharma Launches HemiClor® 12.5 mg, the First FDA-Approved Low-Dose Chlorthalidone Tablet for Hypertension

In Europe, Samsung Bioepis begins the commercialization of BYOOVIZ®, a biosimilar to Lucentis (Ranibizumab)

In Europe, Samsung Bioepis begins the commercialization of BYOOVIZ®, a biosimilar to Lucentis (Ranibizumab)

Leukogene Therapeutics’ M2T-CD33 (LTI-214) has received Orphan Drug Designation from the U.S. FDA for the treatment of Acute Myeloid Leukemia

Leukogene Therapeutics’ M2T-CD33 (LTI-214) has received Orphan Drug Designation from the U.S. FDA for the treatment of Acute Myeloid Leukemia

Nestlé and IdB Holding S.p.A. sign VOWST® licensing deal in Europe

Nestlé and IdB Holding S.p.A. sign VOWST® licensing deal in Europe

Dr. Oregonin Completes U.S. FDA Registration for OLTIS DENTAL-X, Unveiling Oral Care Innovation Rooted in Trans-Pacific Alder Research

Dr. Oregonin Completes U.S. FDA Registration for OLTIS DENTAL-X, Unveiling Oral Care Innovation Rooted in Trans-Pacific Alder Research

  • Dr. Oregonin Inc
  • 06 Oct 2026
SHARx Warns: The Pharmacy Budget Trap — Why Discounts Alone Cannot Control Total Spending

SHARx Warns: The Pharmacy Budget Trap — Why Discounts Alone Cannot Control Total Spending

  • SHARx
  • 05 Oct 2026
Aptar Pharma Launched Premia™ Precision, Establishing a New Quality Standard for Demanding Injectable Therapies

Aptar Pharma Launched Premia™ Precision, Establishing a New Quality Standard for Demanding Injectable Therapies

  • Aptar Pharma
  • 05 Oct 2026
Hovione to Bring Next-Generation Continuous Tableting to the U.S. with the World’s First ConsiGma® CDC Flex Commissioning

Hovione to Bring Next-Generation Continuous Tableting to the U.S. with the World’s First ConsiGma® CDC Flex Commissioning

  • Hovione
  • 04 Oct 2026
CaseBioscience® Joins Team Awarded Up to $7.3 Million by ARPA-H to Advance Ambient Preservation of Cell Therapies

CaseBioscience® Joins Team Awarded Up to $7.3 Million by ARPA-H to Advance Ambient Preservation of Cell Therapies

  • CaseBioscience
  • 02 Oct 2026
Ensera Launched Alliance Network with SHL Medical, Stevanato Group, Ypsomed, Argonaut, and American Injectables.

Ensera Launched Alliance Network with SHL Medical, Stevanato Group, Ypsomed, Argonaut, and American Injectables.

  • Ensera
  • 02 Oct 2026

Most Popular
October   2026
M T W T F S S
      1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31  

User Area

Discover

Engage with Us

© Pharmaceutical Era — A product of HISSM. All Rights Reserved.